Ovid Therapeutics (OVID) vs Puma Biotechnology, Inc. (PBYI)

Ovid Therapeutics and Puma Biotechnology, Inc. are both Biotechnology companies. Ovid Therapeutics and Puma Biotechnology, Inc. are of similar size ($506.9M and $487.3M). Ovid Therapeutics has negative trailing earnings, so its P/E is not meaningful; Puma Biotechnology, Inc. trades at 18.1×. Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against −2.86%. Puma Biotechnology, Inc. has the higher net margin (11.6% vs −439.1%) and the higher return on invested capital (42.6% vs −35.1%). Across the 18 metrics below, Puma Biotechnology, Inc. leads on 13 and Ovid Therapeutics on 5.